Ophthalmology · Huntington, NY
NPI
1669406492
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
755 Park Ave Ste 100
Huntington, NY, 11743
Phone (631) 397-1241
Groups this clinician bills Medicare through
Medicare paid, 2024
$223K
2,415 services
Medicare patients, 2024
512
Average age 79
Drug cost, 2024
$486K
3,017 prescriptions
Company payments, 2025
$87.07
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul L Krawitz was code 92083 (vision, hearing, and speech services), 456 times for 296 patients. In total Paul L Krawitz billed 2,415 services in 40 codes, and Medicare paid $223K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92083 Vision, Hearing, and Speech Services | Office | 456 | 296 | $54.97 | $25K |
| 92133 Computerized Ophthalmic Imaging | Office | 381 | 272 | $28.89 | $11K |
| 92014 Ophthalmological E&M | Office | 335 | 263 | $98.06 | $33K |
| 99214 Office E&M - Established | Office | 259 | 211 | $98.84 | $26K |
| 99213 Office E&M - Established | Office | 230 | 160 | $77.02 | $18K |
| 92250 Angiography | Office | 137 | 129 | $27.61 | $3,782 |
| 92136 Ultrasound - Nonspecific | Office | 109 | 73 | $32.43 | $3,535 |
| 66984 Cataract Surgery | Facility | 85 | 50 | $498.44 | $42K |
| 92012 Ophthalmological E&M | Office | 81 | 54 | $74.79 | $6,058 |
| 92134 Computerized Ophthalmic Imaging | Office | 52 | 49 | $29.85 | $1,552 |
| 92020 Ophthalmological E&M | Office | 50 | 47 | $24.94 | $1,247 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 37 | 36 | $14.72 | $545 |
| 92025 Test - Miscellaneous | Office | 33 | 32 | $28.78 | $950 |
| 66821 Cataract Surgery | Office | 28 | 24 | $309.52 | $8,667 |
| 99204 Office E&M - New | Office | 24 | 24 | $121.91 | $2,926 |
By year: 2022 $493K for 5,506 services; 2023 $497K for 5,570 services; 2024 $223K for 2,415 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 143 | 72 | $22.03 | $3,150 |
| 83516 Immunoassay | 24 | 13 | $11.30 | $271 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul L Krawitz prescribed most often to Medicare patients was Latanoprost, with 497 prescriptions and refills. In total Paul L Krawitz wrote 3,017 Medicare prescriptions that cost $486K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 497 | 1,040 | 144 | $5,490 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 404 | 802 | 102 | $6,360 |
| Timolol Maleate Generic | 310 | 636 | 86 | $4,253 |
| Brimonidine Tartrate Generic | 188 | 274 | 42 | $10K |
| Ofloxacin Generic | 153 | 160 | 91 | $1,701 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 130 | 216 | 38 | $76K |
| Dorzolamide Hcl Generic | 106 | 178 | 28 | $1,473 |
| Vyzulta Latanoprostene Bunod | 94 | 153 | 28 | $46K |
| Simbrinza Brinzolamide/Brimonidine Tart | 89 | 127 | 22 | $23K |
| Bromfenac Sodium Generic | 81 | 81 | 38 | $10K |
| Alphagan P Brimonidine Tartrate | 78 | 94 | 16 | $19K |
| Inveltys Loteprednol Etabonate | 77 | 77 | 32 | $22K |
| Prednisolone Acetate Generic | 75 | 137 | 35 | $2,680 |
| Pilocarpine Hcl Generic | 62 | 160 | 23 | $3,533 |
| Restasis Cyclosporine | 56 | 104 | 21 | $62K |
Brand drugs: 1,156 claims; generic drugs: 1,861 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul L Krawitz $87.07 ($87.07 in general payments such as food, travel and fees) from 3 companies. The largest payer was Tarsus Pharmaceuticals, Inc. with $30.71.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.